|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 01, 2017 ) Anti-Hypertensive Therapeutics Market Hypertension is a serious and common medical condition characterized by elevated blood pressure. It is commonly seen in the aging population, and in people with sedentary lifestyles and obesity. As one of the most significant preventable causes of death worldwide, early diagnosis of the condition is crucial to improve health outcomes.
Browse market data tables and 45 figures evenly distributed through 110 pages and in-depth TOC on Anti-Hypertensive Therapeutics Market Report@ https://www.marketreportsworld.com/10293449
Scope of this Anti-Hypertensive Therapeutics Market Research Report:
· The Asia-Pacific antihypertensive market will be valued at $27 billion in 2022, growing from $19.1 billion in 2015 at a CAGR of 5.1%. Anti-Hypertensive Therapeutics Market Hypertension prevalence is a prominent contributor to market size in the assessed countries. The market is mostly dominated by generics, and there are only a few patented products
Ø Will generics continue to dominate treatment?
Ø How do the elderly populations and their associated risk factors affect prevalence?
Ø What effect will the patent expirations of currently branded therapies have on market value?
· The current anti-hypertensive therapeutics market pipeline is weak, comprising 112 molecules in various stages of development, dominated by small molecules
Ø Which molecular targets appear most frequently in the pipeline?
Ø Is there potential for the pipeline to address unmet needs within the anti-hypertensive market?
· The market forecasts indicate that Japan will contribute the most to the Asia-Pacific market value, due to the high annual cost of therapy. Growth in market size is projected to vary considerably across the five assessed markets
Ø How will the annual cost of therapy and market size vary between the five Asia-Pacific markets?
Ø How could changes in risk factors such as aging population, metabolic disorders and high salt intake influence the market?
Ø Various drivers and barriers will influence the market over the forecast period.
Ø What are the barriers that limit the uptake of premium-priced therapeutics in the assessed countries?
Ø Which factors are most likely to drive the market in these countries?
Get a Sample PDF of Anti-Hypertensive Therapeutics Market Research Report@ https://www.marketreportsworld.com/enquiry/request-sample/10293449
The marketed products landscape for Anti-Hypertensive Therapeutics Market hypertension comprises a wide range of treatment options, which includes angiotensin converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, beta blockers, renin inhibitors, and diuretics. These are used both as monotherapy and combination therapy (including fixed-dose combinations), and the proportion of patients treated using the various therapy approaches varies from country to country.
Major TOC included in this Anti-Hypertensive Therapeutics Market Report:
· Marketed Products
· Pipeline Analysis
· Clinical Trial Analysis
· Multi-Scenario Forecast
· Drivers and Barriers
· Deals and Strategic Consolidations
Purchase Anti-Hypertensive Therapeutics Market Report@ https://www.marketreportsworld.com/purchase/10293449
Price of Report: $4995 (Single User Licence)
Key Reasons to Purchase this Anti-Hypertensive Therapeutics Market Report:
· Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.
· Visualize the composition of the anti-hypertensive market in terms of the dominant therapies, and their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the market.
· Analyse the anti-hypertensive pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target Anti-Hypertensive Therapeutics Market.
· Consider market opportunities and potential risks by examining trends in Anti-Hypertensive Therapeutics Market hypertension clinical trial size, duration, and failure rate by stage of development, molecule type, and mechanism of action.
Enquiry for Discount before Buying@ https://www.marketreportsworld.com/enquiry/pre-order-enquiry/10293449
Markets Reports World
Ameya Pingaley
+1 408 520 9750
sales@marketreportsworld.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
